Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Roxadustat Versus Erythropoietin for Anaemia Treatment in Diabetic Nephropathy

NCT07786168 is registered in ClinicalTrials.gov with Hanzla Arshad as lead sponsor.

NCT NCT07786168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07786168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Roxadustat Versus Erythropoietin for Anaemia Treatment in Diabetic Nephropathy
Lead sponsor
Hanzla Arshad
Phase
Not applicable
Overall status
Completed
Start date
December 20, 2025
Completion date
June 20, 2026
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic kidney disease, diabetic nephropathy